7070 results for
Refine Your Search
Exercise for blood cancer patients
Table of contents:Exercise for Blood Cancer PatientsWhy is being physically active important for blood cancer patients?Goals of an exercise progra…
Champions in myeloma research, Part 2: A conversation with Suzanne Lentzsch, M.D., Ph.D.
To commemorate both Myeloma Awareness Month and Women’s History Month during March, I’ve been talking with LLS-funded women scientists who are driving…
Balancing fiscal responsibility with saving and improving lives
Table of contents:Balancing Fiscal Responsibility with Saving and Improving LivesThe LLS Bold Goal: Accelerate Progress in Blood CancerLLS’s role in p…
The Future of Myeloma Treatment: What’s Next?
Topics CoveredWe invite you to learn more about:Current myeloma treatmentsWhat the future holds for myeloma treatmentSide-effect management …
News Release
Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline
Paris, March 20, 2025. Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under w…
Education Resources
BioInvent Receives FDA Orphan Drug Designation for BI-1808 for the Treatment of T-cell Lymphoma
Lund, Sweden – March 20, 2025 – BioInvent International AB (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of nov…
Advocacy
What’s Next on the Roadmap: Finding Primary Care
Join us for a panel discussion on transitioning to primary care after a cancer diagnosis. Transitioning from the oncologist to a primary care provider…
Education Resources
How the ACA saved me and other young cancer patients
Cancer is disruptive at any age. When you’re a young adult with cancer, a lot might go into “pause” mode: relationships and dating, your education, yo…
Empoderando a los Promotores de Salud: Una Serie Educativa sobre los Cánceres de la Sangre
Estos videos en español están diseñados para fortalecer el conocimiento de los Promotores de Salud y conectar a las comunidades hispanas y latinas con…
Education Resources
Solu Therapeutics Closes $41M Series A Financing and Announces First Patient Dosed in Phase 1 Clinical Trial of STX-0712 in Patients with CMML
BOSTON, Mass – April 9, 2024 – Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunolog…
Education Resources
Multiple Myeloma (MM): Diagnosis, Treatment and Side Effect Management
This activity is intended for oncology nurse practitioners, nurses, and social workers involved in the care of patients with multiple myeloma (MM).
Education Resources
A race for blood cancer research
Caring about something makes you want to take action. To get moving. And when you care about people with blood cancer, you might feel that pull more u…
Tony
It was 40 years ago that Tony was diagnosed with acute lymphoblastic leukemia (ALL) at age 2. Back then, the disease wasn't very well understood, and …
Las estrellas brillarán, el sol también
.article-header { margin-bottom: 20px !important; } .btn-contextual { color: #000 !important; border-bottom: 3px solid #c00 !important; }…
Education Resources
Using the power of social media to reach Spanish-speaking communities
Para leer este post en español, haga clic aquí.Imagine facing a health crisis—like a blood cancer diagnosis—while you’re away from home. Now imagine y…
5 Reasons why I’m grateful for LLS Volunteers
Message from Andy Kolb Message from Andy Kolb 1. You are the heart, soul, and voice of the LLS community. No…
Innovations in Blood Cancer Treatment: Navigating CAR T-cell and Bispecific Therapies
Live symposium was held during the Oncology Nursing Society’s (ONS) 50th Annual Congress on April 10, 2025.
Education Resources
United To End Blood Cancer: Dedicated Volunteers Across the U.S. are Helping Patients Live Longer Better Lives
Business & Community Leaders Join The Leukemia & Lymphoma Society's 2025 Visionaries of the Year 36th Annual Philanthropic Competition …
Education Resources
LLS Expands its Global Master Trial for Hard-To-Treat Leukemias in Children
Marks the First-Ever Global Pediatric Trial for Menin InhibitorsThe PedAL (Pediatric Acute Leukemia) Master Trial is at the heart of LLS’s Dare to Dre…
News Release
Isabel
I never expected to have my whole adult life colored by cancer. In the fall of my freshman year of college, I was diagnosed with chronic myelogenous l…
Shirley
The Boston Marathon marked my 33rd fundraiser for The Leukemia & Lymphoma Society (LLS), the 27th race with Team In Training (TNT), and the 6th Abbott…
Julie
My name is Julie. I’m a loving mother of three outstanding kids, a successful businesswoman, wife, breast cancer survivor, and now mother of a true ca…
Rex
In December 2023, I woke up in the middle of the night and couldn’t catch my breath, so my wife called an ambulance. I was taken to a nearby hospital …
Ally
I was diagnosed with Hodgkin lymphoma (HL) in October 2024 and began chemotherapy (my last is April 25). My best friend and I were supposed to run a h…
Dare 2 Dream
Mayra
I am 28 years old and a mother of two. Last year on December 19, 2024, I was diagnosed with acute myeloid leukemia (AML), an aggressive blood cancer. …
Dare 2 Dream